Cardiac Autonomic Regulation Enhancement Through Exercise Trial

NCT ID: NCT00845091

Last Updated: 2014-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

22 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-02-28

Study Completion Date

2011-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The current research study proposes to examine participants with implantable cardioverter defibrillators (ICD) who are randomly assigned to either an exercise training program intervention or a heart healthy education program intervention. We will look at changes in the functioning of the autonomic nervous system over time and between intervention groups. We are also going to be looking at changes in frequencies of the ICD participants' heart arrhythmias and ICD therapies (e.g., pacing, shock).; as well as, changes in exercise tolerance, psychological well-being, and quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Disease, Arrhythmias

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Exercise

moderate-intensity, low-impact, supervised, aerobic exercise

Group Type EXPERIMENTAL

Exercise

Intervention Type BEHAVIORAL

moderate-intensity, low-impact, supervised, aerobic exercise

Heart Healthy Education

Educational topics on heart health (e.g., nutrition, smoking, sleep)

Group Type ACTIVE_COMPARATOR

Heart Healthy Education

Intervention Type BEHAVIORAL

Educational topics related to heart health (e.g., nutrition, smoking, sleep)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise

moderate-intensity, low-impact, supervised, aerobic exercise

Intervention Type BEHAVIORAL

Heart Healthy Education

Educational topics related to heart health (e.g., nutrition, smoking, sleep)

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult ICD patients (≥ 18 years of age)
* received an ICD for secondary prevention, cardiac diagnosis of: ventricular fibrillation, OR ventricular tachycardia, OR cardiac arrest, OR syncope with ventricular tachycardia inducible by programmed stimulation (EPS), AND
* either diagnosed coronary artery disease AND/OR prior myocardial infarction, or non-ischemic dilated cardiomyopathy
* meet functional NYHA Class I or II heart failure or angina symptoms
* ICD patients need to be sedentary, defined as not engaging in structured exercise more than once weekly, or an accumulation of less than 60 minutes of moderate intensity aerobic activity over the course of the week, for the past 3 months.
* deemed medically stable by their cardiologist and have received approval by their cardiologist to engage in an exercise program
* Stable (unchanged) cardiac and psychopharmacologic medications in the 3 months prior to study enrollment
* Able to read and write English
* able to commit to the 3-month exercise/heart healthy program attending 3 times per week (36 sessions)
* able to commit to the 3 assessments (pre, post-treatment, 3-month follow-up; 6-month duration)

Exclusion Criteria

* Patients who meet functional NYHA Class III or IV heart failure or angina symptoms
* sinus node dysfunction that requires atrial pacing
* atrial fibrillation
* bi-ventricular ICD
* are pacemaker-dependent
* diagnosis of Brugada's Syndrome
* diagnosis of arrhythmogenic right ventricular dysplasia
* complex congenital heart disease
* orthopedic restrictions, limitations, or disabilities that would jeopardize the patient's safety during exercise or form completing the treadmill stress test
* Neurocognitive or cognitive impairments that will result in nonadherence (based on clinical evaluation)
* Unstable angina
* resting systolic blood pressure \>180mmHg or resting diastolic blood pressure \>110mm Hg will be evaluated on a case-by-case basis
* orthostatic blood pressure drop of \>20mm Hg with symptoms
* critical aortic stenosis (peak systolic pressure gradient \>50mm Hg with aortic valve orifice area \<0.75cm2 in average size adult)
* acute systemic illness or fever
* uncontrolled atrial or ventricular arrhythmias
* uncontrolled sinus tachycardia (\>120 beats/min)
* uncompensated CHF
* 3rd degree AV block (without pacemaker)
* active pericarditis or myocarditis
* recent embolism; thrombophlebitis
* resting ST segment displacement (\>2mm)
* uncontrolled diabetes (resting blood glucose \>400mg/dl)
* metabolic problems, such as acute, hypo or hyperkalemia, hypovolemia
* recent strongly positive exercise test as achieved by: significant decrease in systolic blood pressure with increasing workload, OR early onset, horizontal or downsloping ST segment depression (4mm), OR prolonged electrocardiogram (ECG) changes during recovery
* hypertrophic obstructive cardiomyopathy
* severe pulmonary hypertension
* patients who do not pass the exercise stress test
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Miriam Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Eva R. Serber

Assistant Professor (Research)

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eva R Serber, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

The Miriam Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Miriam Hospital Centers for Behavioral and Preventive Medicine

Providence, Rhode Island, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Palmer K, Tilkemeier PL, Buxton AE, Niaura R, Marcus B, Todaro J, Serber ER. Ratings of perceived exertion and physiological responses during exercise testing among ICD patients. Poster presented at the 32nd Annual Meeting of the Society for Behavioral Medicine, New Orleans, LA.; Abstract B-1621, Rapid Communications, April 2012.

Reference Type BACKGROUND

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R21HL092340-01A1

Identifier Type: NIH

Identifier Source: secondary_id

View Link

RIH IRB, CMTT: 0177-08

Identifier Type: -

Identifier Source: secondary_id

HL092340

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.